Gefitinib (250mg) & GEFISTERIS 250: Sterispharma Medications: Quality and Affordability Combined

GEFISTERIS 250

Gefitinib (250mg)

GEFISTERIS 250 is a medication containing Gefitinib 250mg dosage. It belongs to the class of tyrosine kinase inhibitors and is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic mutations. This article provides a detailed overview of GEFISTERIS 250, including its uses, potential side effects, recommended dosage, and pricing information, helping individuals understand its role in managing NSCLC effectively.

Understanding GEFISTERIS 250

GEFISTERIS 250 is indicated for the treatment of patients with metastatic NSCLC that harbors activating mutations in the epidermal growth factor receptor (EGFR) gene. It works by blocking the signals within cancer cells that promote their growth and division, thereby slowing down or inhibiting the progression of NSCLC.

Key Uses of GEFISTERIS 250

GEFISTERIS 250 is prescribed for the following purposes:

1. Metastatic Non-Small Cell Lung Cancer (NSCLC): It is used as a first-line treatment in patients with NSCLC that carries EGFR mutations, particularly exon 19 deletions or exon 21 (L858R) substitution mutations.
2. EGFR Mutation-Positive NSCLC: GEFISTERIS 250 is effective in treating NSCLC with specific EGFR mutations, improving progression-free survival and overall response rates.
3. Maintenance Therapy: In some cases, it may be prescribed as maintenance therapy after initial treatment with chemotherapy or other targeted therapies.

How GEFISTERIS 250 Works

Gefitinib, the active ingredient in GEFISTERIS 250, selectively inhibits the tyrosine kinase activity of the EGFR, which is often overexpressed or mutated in NSCLC. By blocking these signals, Gefitinib suppresses the growth and survival of cancer cells that rely on EGFR signaling for proliferation.

Recommended Dosage

The recommended dosage of GEFISTERIS 250 is usually 250mg taken orally once daily, with or without food. It is important to follow the prescribed dosage and schedule as directed by a healthcare provider. Dosage adjustments or interruptions may be necessary based on individual patient response and tolerability.

Potential Side Effects of GEFISTERIS 250

While GEFISTERIS 250 is generally well-tolerated, some individuals may experience side effects, including:

• Diarrhea
• Skin rash or itching
• Fatigue
• Nausea or vomiting
• Loss of appetite

Less common but more severe side effects may include interstitial lung disease, liver problems, or changes in vision. It is essential to report any unusual or persistent side effects to a healthcare provider promptly.

Precautions and Warnings

• Pregnancy and Breastfeeding: GEFISTERIS 250 may cause harm to unborn babies and is not recommended during pregnancy or breastfeeding.
• Liver or Kidney Impairment: Dosage adjustments may be necessary in patients with impaired liver or kidney function.
• Drug Interactions: Inform your doctor about all medications, supplements, or herbal products you are taking to avoid potential interactions with GEFISTERIS 250.

Price and Availability

GEFISTERIS 250, available as Gefitinib tablets, is typically available in pharmacies and may require a prescription. Prices can vary based on brand, quantity, and location. It is advisable to compare prices and check for financial assistance programs or insurance coverage for GEFISTERIS 250.

Conclusion

GEFISTERIS 250 is a valuable medication for the treatment of metastatic NSCLC with specific EGFR mutations, offering improved outcomes and disease control in eligible patients. By understanding its uses, potential side effects, recommended dosage, and pricing information, individuals and healthcare providers can make informed decisions regarding its use in managing NSCLC effectively. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW